1 / 5
Product description
Purity 99%min Trelagliptin Succinate CAS Steady Supply
Trelagliptin succinate (SYR-472 succinate) CAS:1029877-94-8 is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed for the treatment of type 2 diabetes (T2D).Trelagliptin succinate CAS:1029877-94-8 is a once-weekly dipeptidyl peptidase-IV (DPP-4) inhibitor. It controls blood glucose levels by selectively and continually inhibiting DPP-4, an enzyme that causes the inactivation of glucagon-like peptide-1 and glucagon-dependent insulinotropic polypeptide, incretin hormones that play an important role in blood glucose regulation. The inhibition of DPP-4 increases insulin secretion depending on blood glucose concentration, thereby controlling blood glucose levels. It is indicated for the treatment of type 2 diabetes.
Trelagliptin succinate CAS:1029877-94-8 could be supplied in commercial size with competitive price.
Trelagliptin succinate is suitable for type 2 diabetes. It is a weekly dipeptidyl peptidase IV (DPP-4) inhibitor. It can control blood sugar levels by selectively
and continuously inhibiting DPP-4. DPP-4 is an enzyme that can trigger the inactivation of incretin (glucagon-like peptide-1 (GLP-1) and glucose-dependent
insulin-promoting polypeptide (GIP). It plays an important role in regulation. Inhibiting DPP-4 can increase blood glucose level-dependent insulin secretion,
thereby controlling blood glucose levels.
Trelagliptin succinate CAS 1029877-94-8
Grade Standard :Medicine Grade
Purity: 99%
Appearance : White Powder
Packing : 100G/Bag
Molecular Formula: C22H26FN5O6
Character: This product is soluble in dimethyl sulfoxide or water, slightly soluble in methanol, slightly soluble in absolute ethanol, very slightly soluble in acetonitrile, almost insoluble in methylene chloride
Kind :Pharmaceutical raw materials
Industry: medicine
Area :Antihypertensive and hypoglycemic drugs
Related Products Troglitin Succinate Tablets
Send your inquiry to this supplier